In an exclusive interview, one of UCLA's top scientists spoke out about what the disruptions in funding could mean to you and to science.

Goodman also blamed "institutional inertia" and "circular reasoning" – that agencies had always experimented on animals – for not innovating outside animals, while Locke said feds were "passive and ...

Here, we explain the facts behind several more of Robert F. Kennedy Jr.’s claims during his two Senate hearings as nominee ...

A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, ...

Research in fruit flies has identified specific groups of cholinergic brain cells that are involved in alcohol-induced insomnia. This work could ultimately lead to targeted treatments for ...

Alcohol use disorder, which affects over 10% of Americans, can lead to persistent and serious insomnia. Difficulties falling ...

A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers, and it has potential for other cancers as well. Scientists led by ...

Aging research has experienced substantial advancements in the past decade, particularly in understanding the interrelation ...

A new nasal delivery method for amifostine could protect healthy tissue during pancreatic cancer radiation therapy, ...

Professor Kwang-Hyun Cho's research team has recently been highlighted for their work on developing an original technology ...

The FDA approved Datroway to treat metastatic or unresectable HR+/HER2- breast cancer in people who have tried standard chemo ...

In patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine (T-DM1) reduced the long-term risk of death or invasive disease by 46% and ...